Search Results 1041-1050 of 17726 for Prednisone

1. A study to investigate the efficacy, safety, and pharmacokinetics of oral rilzabrutinib compared with placebo in participants 18 years of age and older with warm autoimmune hemolytic anemia - Mayo Clinic

   ... prednisone or equivalent per day], CS-dependent wAIHA [defined as need to continue on prednisone or equivalent at a dose of >10 mg/day to maintain a ...

2. Cilostazol (oral route) - Side effects & dosage - Mayo Clinic

   Cilostazol improves the flow of blood through the blood vessels. It is used to reduce leg pain caused by poor circulation (intermittent claudication).

3. A Study Testing the Effectiveness and Safety of KPL-301 in Patients with Giant Cell Arteritis - Mayo Clinic

   Known history of allergy or reaction to any component of the mavrilimumab or placebo formulation or to any other biologic therapy or prednisone or any of its ...

4. A Study To Evaluate the Effectiveness, Safety, And Tolerability of a Clostridium Difficile Vaccine In Adults 50 Years of Age and Older - Mayo Clinic

   ... prednisone or equivalent) for ≥ 14 days within 28 days of enrollment; or. Receipt of chronic systemic treatment with other known immunosuppressant ...

5. A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

   * Received systemic corticosteroids equivalent to prednisone >10 mg/day or equivalent within 2 weeks of screening period. * Use of any of the following ...

6. CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies - Mayo Clinic

   ... prednisone or equivalent forms of steroids * History of severe immediate hypersensitivity reaction to CART19, stem cell infusion dimethyl sulfoxide (DMSO) ...

7. Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 (enrollment by invitation only) - Mayo Clinic

   Use of chronic oral corticosteroids for a non-COVID-19-related condition in a dose higher than prednisone 10 mg or equivalent per day; History of, or current ...

8. A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma - Mayo Clinic

   Ongoing treatment with corticosteroids with a dose >10 mg prednisone or equivalent per day at the time of randomization; or >280 mg cumulative prednisone ...

9. Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia - Mayo Clinic

   Chronic immunosuppression therapy (10 mg or greater of prednisone or equivalence/ day) 8. Current or anticipated chemotherapy/radiotherapy during study ...

10. Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Subjects who are currently using more than 5mg/day of prednisone (or an equivalent glucocorticoid exceeding physiologic replacement levels). Prior treatment ...